Opthea’s lead biologic drug candidate OPT-302, which is under investigation for the treatment of wet AMD, received nonproprietary drug name sozinibercept, which is a critical step in the FDA approval process.

David Elliott, PhD, FCOptom, FAAO, comes to Optometry and Vision Science after over a decade of leading the success of Ophthalmic & Physiological Optics.

According to Tarsus Pharmaceuticals, lotilaner ophthalmic solution 0.25% is the first approved therapeutic for Demodex blepharitis, and has demonstrated efficacy across multiple clinical measures of disease.

Pediatric keratoconus is often more challenging to diagnose, resulting in treatment delay and vision loss.

Combining simple and advanced methods can lead to optimal patient outcomes.

Catch up on what happened in optometry during the week of July 17-July 21.

Diana Canto-Sims, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Successfully improving visual function in patients with MTBI requires an interdisciplinary approach and a collaborative effort between the patient and all involved allied health care providers.

Well-fitting lenses greatly improve quality of life for patients.

With this new funding, Smartlens gives the possibility of new treatment for glaucoma with miLens.

A recent study found that the use of low-dose atropine drops is ineffective in slowing pediatric myopia progression, contradicting a previous study.

Hear how the CRU Eye Symposium caters to having current, relevant, and useful education.

The company has completed evaluation on candidates and selected a single drug candidate to move forward into clinical trials.

A single, consistent modality leads to better geographic atrophy tracking.

Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.

Dina Erickson, OD, FAAO, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from her talk on glaucoma suspects.

Nominations for the 2023 awards will close July 31, 2023.

Ami Halvorson, OD, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from her talk on ophthalmic surgery options.

A recent study demonstrates the safety and efficacy of treating eyes with cross-linking after keratoconus relapses following keratoplasty.